Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence

Molecular Psychiatry

Volumn 4, Issue 5, 1999, Pages 484-487

  Comings, D E ^a   Gonzalez, N ^a   Wu, S ^a   Saucier, G ^b   Johnson, P ^c   Verde, R ^c   MacMurray, J P ^d  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF OREGON   (United States)

^c Jerry L Pettis VA Hospital   (United States)

^d LOMA LINDA UNIVERSITY   (United States)

Author keywords

Addiction; Dopamine; DRD3; Genetics

Indexed keywords

ALCOHOL; AMPHETAMINE; COCAINE; DOPAMINE 3 RECEPTOR; OPIATE;

ARTICLE; CAUCASIAN; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MENTAL DISEASE; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 0032730338     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000542     Document Type: Article

References (28)

1. 3 dopamine receptors. Science 1993; 260: 1814-1815.
2. 2 Caine SB, Koob GF. Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose effect function to the left under different schedules in the rat. Behavioral Pharmacol 1995; 6: 333-347.
3. 3 Nader MA, Mach RH. Self-administration of the dopamine D3 agonist 7-OH-DPAT in rhesus monkeys is modified by prior cocaine exposure. Psychopharmacology (Berl) 1996; 125: 13-22.
4. 4 Staley JK, Mash DC. Adoptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities. J Neurosci 1996; 16: 6100-6106.
5. 3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. Molec Brain Res 1997; 45: 335-339.
6. 3 receptors linked to the development of cocaine dependence? Mol Psychiatry 1997; 2: 7-8.
7. 7 Lannfelt L, Sokoloff P, Martres M-P, Pilon C, Giros B, Jonsson E et al. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders. Psychiat Genet 1992; 2: 249-256.
8. 8 Crocq M-A, Mant R, Asherson P, Williams J, Hode Y, Mayerova A et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992; 29: 858-860.
9. 9 Asherson P, Mant R, Holmans P, Williams J, Cardino A, Murphy K et al. Linkage, association and mutational analysis of the dopamine D3 receptor gene in schizophrenia. Mol Psychiatry 1996; 1: 125-132.
10. 10 Comings DF, Muhleman D, Dietz C, Dino M, Legro R, Gade R. Association between Tourette's syndrome and homozygosity at the dopamine-D3 receptor gene. Lancet 1993; 341: 906.
11. 11 Comings DE, Rosenthal RJ, Lesieur HR, Rugle L, Muhleman D, Chiu C et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996; 6: 223-234.
12. 12 Jönsson E, Sedvall G, Brené S, Gustavsson JP, Geijer T, Terenius L et al. Dopamine-related genes and their relationship to monamine metabolites in CSF. Biol Psychiatry 1996; 40: 1032-1043.
13. 13 Krebs M-O, Sautel F, Bourdel M-C, Sokoloff P, Schwartz J-C, Olie J-P et al. Dopamine D3 receptor gene variants in substance abuse in schizophrenia. Mol Psychiatry 1998; 3: 337-341.
14. 14 Duaux E, Gorwood P, Griffon N, Mourdeel M-C, Sautel F, Skoloff P et al. Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence. Mol Psychiatry 1998; 3: 333-336.
15. 15 Freimer M, Kranzler H, Satel S, LaCorbelle J, Skipsey K, Charney D et al. No association between D3 dopmaine receptor (DRD3) alleles and cocaine dependence. Addiction Biology 1998; 1: 281-287.
16. 16 Cadoret RJ, Troughton E, O'Gorman TW, Heywood E. An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry 1986; 43: 1131-1136.
17. 17 Tsuang MT, Lyons MJ, Eisen SA, Glodberg J, True W, Lin N et al. Genetic influences on DMS-III-R drug abuse and dependence: a study of 3372 twin pairs. Am J Med Gen (Neuropsych Genet) 1996; 67: 473-477.
18. 18 Uhl GR, Elmer GI, LaBuda MC, Pickens RW. Genetic influences in drug abuse. In: Bloom FE, Kupfer DI (eds). Psychopharmacology. The Fourth Generation of Progress. Raven Press: New York, 1955, pp 1793-1896.
19. 19 Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D et al. Multiply additive associations: a technique for the identification of genes in polygenic disorders. Am J Med Genet (Neuropsychiatric Genet) 1998; 81: 989.
20. 2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993; 33: 271-285.
21. 21 Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend 1994; 34: 175-180.
22. 22 Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D et al. Genetic vulnerability to drug abuse. The D2 dopamine receptor TaqI B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992; 49: 723-727.
23. 23 O'Hara BF, Smith SS, Bird G, Persico AM, Suarez B, Cutting GR et al. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in Black and Caucasian research volunteers. Hum Genet 1993; 43: 209-218.
24. 24 Ball SA, Carroll KM, Rounsaville BJ. Sensation seeking, substance abuse, and psychopathology in treatment-seeking and community cocaine abusers. J Consult Clin Psychol 1994; 62: 1053-1057.
25. 25 Castellani B, Kugle L. A comparison of pathological gamblers to alcoholics and cocaine misusers on impulsivity, sensation seeking, and craving. Int J Addict 1995; 30: 275-289.
26. 26 Robins LN, Helzer J, Croughan J, Ratclif KS. National Institute of Health diagnostic: interview schedule. Arch Gen Psychiatry 1981; 38: 381-389.
27. 27 Hodgins DC, Guebaly N. More data on the Addiction Severity Index. Reliability and validity with the mentally ill substance abuser. J Nerv Ment Dis 1992; 180: 197-201.
28. 28 Selzer ML. The Michigan Alcoholism Screening Test: the quest for a new diagnostic instrument. Am J Psychiatry 1971; 127: 89-94.